Ana Martins Costa received an NWO Open Competition Domain Science-XS grant for the project "Development and validation of artificial red blood cells: In-air microencapsulation of a novel oxygen carrier".
Patient care worldwide depends on scarce human blood, and the testing of medical devices (e.g. oxygenators, dialyzers) still relies on human or animal blood. A scalable, universal, and long-term stable artificial blood has long been searched. Current approaches using mammalian hemoglobin and perfluorocarbon carriers suffer limited availability, adverse effects, environmental concerns, and poor production scalability.
We propose an innovative approach to develop artificial erythrocytes:
1) using commercial marine worm hemoglobin as oxygen-carrier,
2) selecting in-air microfluidics to fabricate core-shell-microcapsules that mimic erythrocytes,
3) setting medical device testing as intermediary goal, more feasible, but still with high impact to medical industry.
More recent news
Mon 13 Jul 2026𝗧𝗵𝗲 𝟭𝘀𝘁 𝗪𝗼𝗿𝗸𝘀𝗵𝗼𝗽 𝗼𝗻 𝗡𝗲𝘂𝗿𝗼𝗺𝘂𝘀𝗰𝘂𝗹𝗮𝗿 𝗥𝗼𝗯𝗼𝘁𝗶𝗰𝘀: 𝗔 𝗙𝘂𝗹𝗹-𝗗𝗮𝘆 𝗪𝗼𝗿𝗸𝘀𝗵𝗼𝗽 𝗮𝘁 𝗜𝗘𝗘𝗘/𝗥𝗦𝗝 𝗜𝗥𝗢𝗦 𝟮𝟬𝟮𝟲
Fri 10 Jul 2026OpenUp-regeling van Npuls toegekend aan Universiteit Twente
Wed 1 Jul 2026OCON and the UT connect science and clinical practice in healthcare
Tue 16 Jun 2026Frank Halfwerk received 2026 Springer Nature Editor of Distinction Award - Author Service Award
Fri 29 May 2026Van enkelblessure naar artrose: kunnen we dit stoppen?